Compass Pathways Sued for Stealing Trade Secrets
Compass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual property
Compass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual property
Psychedelic companies rely on novel patents to boost their value, but many players in the space are chasing the same IP
Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.